Frantz Viral Therapeutics
Showing 1 - 25 of 4,750
Vulvar Dysplasia, HPV-Related Vulvar Intraepithelial Neoplasia, Preinvasive Vulvar Disease Trial in Baltimore, Cleveland,
Active, not recruiting
- Vulvar Dysplasia
- +4 more
- artesunate ointment 40%
-
Baltimore, Maryland
- +3 more
Oct 31, 2022
HPV-Related Anal Intraepithelial Neoplasia, AIN2/3, Artesunate Trial in Baltimore, Madison (Artesunate Suppositories)
Completed
- HPV-Related Anal Intraepithelial Neoplasia
- +6 more
- Artesunate Suppositories
-
Baltimore, Maryland
- +1 more
Nov 2, 2021
Cervical Intraepithelial Neoplasia Grade 2/3, High-risk HPV (Any Strain) Trial in Baltimore, Towson (Artesunate Suppositories)
Completed
- Cervical Intraepithelial Neoplasia Grade 2/3
- High-risk HPV (Any Strain)
- Artesunate Suppositories
-
Baltimore, Maryland
- +2 more
Apr 6, 2021
Patients Who Received Gene-Modified Cell Therapy
Enrolling by invitation
- Long-term Follow-up
- Gene-Modified Cell Therapy
-
Philadelphia, PennsylvaniaAbramson Cancer Center Clinical Research Unit, University of Pen
Jul 21, 2022
Vulvar Diseases, HPV Infection, Vulvar HSIL Trial in Cleveland, Mayfield Heights (Artesunate ointment, Placebo ointment)
Not yet recruiting
- Vulvar Diseases
- +12 more
- Artesunate ointment
- Placebo ointment
-
Cleveland, Ohio
- +2 more
Oct 4, 2023
Covid19 Trial in Stanford (Acebilustat, Placebo)
Active, not recruiting
- Covid19
- Acebilustat
- Placebo
-
Stanford, CaliforniaStanford University
May 24, 2022
Intensive Viral Dynamics Substudy of A5248
Completed
- HIV Infections
- Treatment Naive
-
Aurora, Colorado
- +5 more
Oct 28, 2021
Anal High Grade Squamous Intraepithelial Lesion, Anal Precancerous Condition, AIN 2/3 Trial in San Francisco, Chicago, New York
Not yet recruiting
- Anal High Grade Squamous Intraepithelial Lesion
- +5 more
- Artesunate
- Placebo
-
San Francisco, California
- +2 more
Nov 7, 2022
Healthy Trial in London (3SM2-G-CRM197 with squalene adjuvant)
Completed
- Healthy
- 3SM2-G-CRM197 with squalene adjuvant
-
London, Please Select..., United KingdomNIHR Imperial Clinical Research Facility
Jul 25, 2022
HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)
Simple, Safe, Same: Lung Ultrasound for COVID-19
Completed
- Coronavirus
- +2 more
- Lung ultrasound
-
Brescia, Italy
- +8 more
Mar 7, 2022
HIV Trial in Puerto Rico, United States (ALVAC(2)120(B,MN)GNP (vCP1452), Aldesleukin)
Completed
- HIV Infections
- ALVAC(2)120(B,MN)GNP (vCP1452)
- Aldesleukin
-
Birmingham, Alabama
- +25 more
Oct 28, 2021
HIV Trial in United States (Romidepsin, Placebo for Romidepsin)
HIV Trial in United States (Raltegravir (MK-0518), Placebo)
Completed
- HIV Infections
- Raltegravir (MK-0518)
- Placebo
-
Birmingham, Alabama
- +19 more
Nov 2, 2021
SARS-CoV-2 Infection Trial in United States (Moderna COVID-19 Vaccine)
Completed
- SARS-CoV-2 Infection
- Moderna COVID-19 Vaccine
-
Birmingham, Alabama
- +50 more
Dec 1, 2022
HIV Trial in Puerto Rico, United States (NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT), NNRTIs (EFV, NVP), PIs
Completed
- HIV Infections
- NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT)
- +2 more
-
Alhambra, California
- +30 more
Nov 3, 2021
Hemophilia A Trial in Worldwide (SPK-8011)
Recruiting
- Hemophilia A
- SPK-8011
-
Sacramento, California
- +18 more
Jul 15, 2022
Long COVID-19, Long COVID Trial (Paxlovid 25 day dosing, Paxlovid 15 day dosing, Control)
Not yet recruiting
- Long COVID-19
- Long COVID
- Paxlovid 25 day dosing
- +2 more
- (no location specified)
Jul 25, 2023
Influenza, Influenza, Human Trial in Bangkok (Drug: Oseltamivir, Drug: Favipiravir, Drug: Zanamivir)
Not yet recruiting
- Influenza
- Influenza, Human
- Drug: Oseltamivir
- +6 more
-
Bangkok, ThailandFaculty of Tropical Medicine, Mahidol University
Jan 30, 2023